Literature DB >> 33489099

Life After s Loss: Impact of Hepatitis B s Antigen Loss on Future Patient Outcomes.

Daniel Q Huang1,2, Seng Gee Lim1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33489099      PMCID： PMC7805298          DOI： 10.1002/cld.983

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  22 in total

1.  Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

Authors:  Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Masahiro Kobayashi; Norio Akuta; Takashi Someya; Tetsuya Hosaka; Hitomi Sezaki; Mariko Kobayashi; Hiromitsu Kumada
Journal:  Am J Med       Date:  2006-01       Impact factor: 4.965

2.  Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).

Authors:  Kin Seng Liem; Scott Fung; David K Wong; Colina Yim; Seham Noureldin; Jiayun Chen; Jordan J Feld; Bettina E Hansen; Harry L A Janssen
Journal:  Gut       Date:  2019-08-28       Impact factor: 23.059

3.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

Review 4.  Discontinuation of oral antivirals in chronic hepatitis B: A systematic review.

Authors:  George Papatheodoridis; Ioannis Vlachogiannakos; Evangelos Cholongitas; Karsten Wursthorn; Christos Thomadakis; Giota Touloumi; Jörg Petersen
Journal:  Hepatology       Date:  2016-03-04       Impact factor: 17.425

5.  Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.

Authors:  C-H Hung; J-H Wang; S-N Lu; T-H Hu; C-M Lee; C-H Chen
Journal:  J Viral Hepat       Date:  2017-02-22       Impact factor: 3.728

6.  Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s Antigen.

Authors:  Ahmad Samer Alawad; Sungyoung Auh; Daniel Suarez; Marc G Ghany
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-16       Impact factor: 11.382

7.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

Review 8.  Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.

Authors:  Anna S F Lok; Brian J McMahon; Robert S Brown; John B Wong; Ahmed T Ahmed; Wigdan Farah; Jehad Almasri; Fares Alahdab; Khalid Benkhadra; Mohamed A Mouchli; Siddharth Singh; Essa A Mohamed; Abd Moain Abu Dabrh; Larry J Prokop; Zhen Wang; Mohammad Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

9.  Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.

Authors:  Yee Hui Yeo; Hsiu J Ho; Hwai-I Yang; Tai-Chung Tseng; Tetsuya Hosaka; Huy N Trinh; Min-Sun Kwak; Young Min Park; James Yan Yue Fung; Maria Buti; Manuel Rodríguez; Sombat Treeprasertsuk; Carmen Monica Preda; Teerapat Ungtrakul; Phunchai Charatcharoenwitthaya; Xiangyong Li; Jiayi Li; Jian Zhang; Michael Huan Le; Bin Wei; Biyao Zou; An Le; Donghak Jeong; Nicholas Chien; Leslie Kam; Chiao-Chin Lee; Mar Riveiro-Barciela; Doina Istratescu; Tassanee Sriprayoon; Yutian Chong; Tawesak Tanwandee; Mariko Kobayashi; Fumitaka Suzuki; Man-Fung Yuen; Hyo-Suk Lee; Jia-Horng Kao; Anna S Lok; Chun-Ying Wu; Mindie H Nguyen
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

Review 10.  Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.

Authors:  F Liu; X-W Wang; L Chen; P Hu; H Ren; H-D Hu
Journal:  Aliment Pharmacol Ther       Date:  2016-04-27       Impact factor: 8.171
View more
  1 in total

Review 1.  HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.

Authors:  Maryam Moini; Scott Fung
Journal:  Viruses       Date:  2022-03-22       Impact factor: 5.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.